PCVX Vaxcyte, Inc.
$59.47▲ +0.97%
Healthcare
Other
After hours
$59.47▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.68M
Avg Volume (10D) 1.07M
Key Metrics & Fundamentals
Market Cap
$8.85B
P/E Ratio
–
Div Yield
–%
52W Range
30.81 - 65.00
% vs 50 MA
1.86%
% vs 200 MA
9.55%
RSI-14
49.3
MACD Histogram
-0.4200
Beta (1Y vs SPY)
0.90
Free Cash Flow
-$237.05M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$296.85M
COGS
–
Operating Exp
$302.78M
Operating Income
-$302.78M
EBIT
-$302.78M
Pretax Income
-$284.30M
Net Income
-$284.30M
EPS (Diluted)
-1.97
Price & Volume History
Loading chart…
Recent News
Vaxcyte Has $2.5 Billion in Cash and a $605 Million Half-Year Loss. Here's How to Read Its CFO's Latest Insider Filing
Motley Fool · Sep 8, 2026 10:11 AM
A Vaxcyte Executive Just Cashed Options Struck at $5.35. Here's What Long-Term Investors Should Know
Motley Fool · Sep 8, 2026 9:57 AM
Vaxcyte's CEO Parted With Shares for Taxes. Here's What Long-Term Investors Should Know About the Firm
Motley Fool · Sep 8, 2026 9:44 AM
The Next Year Will Define Vaxcyte’s (PCVX) Vaccine Gamble
Insider Monkey · Sep 6, 2026 2:09 PM
Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data
MT Newswires · Sep 3, 2026 9:33 PM
Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
GlobeNewswire · Sep 3, 2026 8:05 PM
Vaxcyte to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 27, 2026 8:05 PM
If You Followed Seth Klarman Into Vaxcyte in May, He Was Already Long Gone
24/7 Wall St. · Aug 16, 2026 7:45 PM
ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer
Business Wire · Aug 11, 2026 12:30 PM
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 5, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PCVX's money flow as a full page
Social Sentiment
Avg -0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.